Profiles for companies starting with 'n'
✉ Email this page to a colleague
Drugs and US Patents for n
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma Ltd | LANSOPRAZOLE | lansoprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 201921-002 | Dec 18, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Novugen | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 211973-002 | Oct 17, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Novartis | MEKINIST | trametinib dimethyl sulfoxide | TABLET;ORAL | 204114-001 | May 29, 2013 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Novartis | NEORAL | cyclosporine | CAPSULE;ORAL | 050715-002 | Jul 14, 1995 | AB1 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Novo | RYBELSUS | semaglutide | TABLET;ORAL | 213051-002 | Sep 20, 2019 | RX | Yes | No | 10,933,120 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Novartis | PLUVICTO | lutetium lu-177 vipivotide tetraxetan | SOLUTION;INTRAVENOUS | 215833-001 | Mar 23, 2022 | RX | Yes | Yes | 10,398,791 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
